{"id":1300,"date":"2021-04-19T15:52:00","date_gmt":"2021-04-19T15:52:00","guid":{"rendered":"https:\/\/futurycapital.vc\/?p=1300"},"modified":"2025-07-09T15:27:48","modified_gmt":"2025-07-09T15:27:48","slug":"frgf-leads-the-financing-round-of-demecan","status":"publish","type":"post","link":"https:\/\/futurycapital.vc\/en\/frgf-leads-the-financing-round-of-demecan\/","title":{"rendered":"FRGF leads the financing round of DEMECAN"},"content":{"rendered":"<p>DEMECAN, Germany\u2019s only independent producer of medical cannabis, has closed another multi-million Euro financing round. The investment will be used for further growth as well as the expansion of the production facility, located near Dresden, into Europe&#8217;s most modern facility for the cultivation and processing of medicinal cannabis.<\/p>\n\n\n\n<p>The investment in the upper single-digit million range comes from private and institutional investors, among whom is new investor Futury Fund as well as existing shareholders, including the btov Private Investor Network.<\/p>\n\n\n\n<p>&#8222;It is DEMECAN\u2019s mission to guarantee the nationwide supply of high-quality medical cannabis for the benefit of patients in Germany. Therefore, we not only focus on the cultivation of medical cannabis but are also active in the field of R&amp;D to develop new and innovative dosage forms,&#8220; explains Dr. Adrian Fischer, physician, co-founder, and CEO of DEMECAN.<\/p>\n\n\n\n<p>This financing round is an important step for DEMECAN in its rapid growth trajectory since being selected as a supplier of medical cannabis for the Federal Republic of Germany in 2019. In addition to product development and distribution, strategic objectives include collaborations with research-based pharmaceutical companies and the coordination and strengthening of operational pharmaceutical distribution.<\/p>\n\n\n\n<p>To implement the corporate strategy, the DEMECAN Group intends to establish a subsidiary in the state of Hessen. The immediate proximity to pharmaceutical companies is critical as is cooperation with smaller cannabis companies in the region. The aim is to establish a dedicated medical cannabis research cluster, where knowledge of medical cannabis is combined with experience from large-scale pharmaceutical production. This will further enable DEMECAN to grow and conduct research more rapidly.<\/p>\n\n\n\n<p>&#8222;DEMECAN has been able to establish itself early on as a leader in the medical cannabis market and we are convinced that it is positioned to take a leading role in Europe as well,&#8220; said Benjamin Krahmer, Managing Director of Futury.<\/p>","protected":false},"excerpt":{"rendered":"<p>DEMECAN, Germany\u2019s only independent producer of medical cannabis, has closed another multi-million Euro financing round. The investment will be used for further growth as well as the expansion of the production facility, located near Dresden, into Europe&#8217;s most modern facility for the cultivation and processing of medicinal cannabis. The investment in the upper single-digit million [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":413,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-1300","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/posts\/1300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/comments?post=1300"}],"version-history":[{"count":1,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/posts\/1300\/revisions"}],"predecessor-version":[{"id":1301,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/posts\/1300\/revisions\/1301"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/media\/413"}],"wp:attachment":[{"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/media?parent=1300"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/categories?post=1300"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/futurycapital.vc\/en\/wp-json\/wp\/v2\/tags?post=1300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}